| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 2 securities · may seek to influence control | ||||||
|
Lava Therapeutics N.V.
13D/A
LVTX · N51517105
|
3.9% |
10/22/2025
Event 10/20/2025
|
||||
| Cooperatieve Gilde Healthcare IV U.A. | 3.9% | |||||
| Gilde Healthcare IV Management B.V. | 3.9% | |||||
| Gilde Healthcare Holding B.V. | 3.9% | |||||
| Manapouri B.V. | 3.9% | |||||
| Martemanshurk B.V. | 3.9% | |||||
|
CVRx, Inc.
13D/A
CVRX · 126638105
|
4.9% |
2/6/2025
Event 2/4/2025
|
||||
| Cooperatieve Gilde Healthcare IV U.A. | 4.9% | |||||
| Gilde Healthcare IV Management B.V. | 4.9% | |||||
| Gilde Healthcare Holding B.V. | 4.9% | |||||
| Manapouri B.V. | 4.9% | |||||
| Martemanshurk B.V. | 4.9% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.